2023 annual financial data
Cellyan Biotechnology 2023 Net margin
Direct answer
Net margin was 7.95%.
Operating income was 1,043,793 USD and net income was 998,196 USD.
Operating cash flow was 1,727,079 USD.
Get free Cellyan Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,555,991 USD
- Operating income
- 1,043,793 USD
- Net income
- 998,196 USD
- Operating cash flow
- 1,727,079 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Cellyan Biotechnology financial years